Literature DB >> 1384340

Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.

O Tiitta1, T Wahlström, J Paavonen, A Linnala, S Sharma, V E Gould, I Virtanen.   

Abstract

Tenascin is an extracellular matrix glycoprotein that is widely expressed during embryogenesis. In adults, it is restricted to select sites, including certain epithelial-stromal interfaces, but is notably enhanced in active inflammatory-reactive processes and in the stroma of many neoplasms. The authors immunostained with the monoclonal antibody (MAb) 100EB2 cryosections of vulvar and cervical biopsies displaying convincing koilocytosis with variable degrees of hyperplasia-dysplasia; in situ carcinomas were included. The presence of human papillomaviruses (HPV) 6, 11, 16, 18, 31, or 33 was confirmed by in situ hybridization in a subset of cases. Findings were compared with normal controls. The study was extended with the MAb 143DB7 that reacted with tenascin in paraffin sections. In normal samples, tenascin immunoreaction appeared as a delicate, continuous rim, in the immediate vicinity of the laminin staining; in parakeratotic areas, the rim was thicker. In foci of hyperplastic-dysplastic epithelium with or without koilocytosis, a distinct increase in tenascin staining was noted; enhanced tenascin often paralleled increasing hyperplasia and dysplasia. In most cervical and vulvar carcinomas in situ, the reactions were intense and extended deeply and raggedly into the underlying stroma. Tenascin was selectively enhanced in the endocervical stroma around inflammed or metaplastic glands. The authors conclude that tenascin is increased in HPV infection associated with epithelial proliferation. Enhancement was most consistently strong and extensive in in situ carcinomas, suggesting a correlation with active phases of epithelial growth and stromal remodeling.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384340      PMCID: PMC1886622     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis.

Authors:  R Chiquet-Ehrismann; E J Mackie; C A Pearson; T Sakakura
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

Review 2.  Tenascin: a hexameric adhesive glycoprotein.

Authors:  P G Natali; L Zardi
Journal:  Int J Cancer Suppl       Date:  1989

3.  Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.

Authors:  V E Gould; G K Koukoulis; I Virtanen
Journal:  Cell Differ Dev       Date:  1990-12-02

4.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.

Authors:  A A Howeedy; I Virtanen; L Laitinen; N S Gould; G K Koukoulis; V E Gould
Journal:  Lab Invest       Date:  1990-12       Impact factor: 5.662

Review 5.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.

Authors:  H zur Hausen
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

6.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

7.  Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions.

Authors:  E Aufderheide; P Ekblom
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

8.  Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy.

Authors:  V A Lightner; F Gumkowski; D D Bigner; H P Erickson
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

9.  Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme.

Authors:  E Aufderheide; R Chiquet-Ehrismann; P Ekblom
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

10.  Laminin is produced by early rat astrocytes in primary culture.

Authors:  P Liesi; D Dahl; A Vaheri
Journal:  J Cell Biol       Date:  1983-03       Impact factor: 10.539

View more
  12 in total

1.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

2.  The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea.

Authors:  A Tuori; I Virtanen; E Aine; H Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

3.  Tenascin in human papillomavirus associated lesions of the uterine cervix.

Authors:  R Pöllänen; Y Soini; S Vuopala; E Läärä; V P Lehto
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

4.  Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymer implants: study of the expression of tenascin and cellular fibronectin.

Authors:  R Kontio; A Salo; R Suuronen; C Lindqvist; J H Meurman; I Virtanen
Journal:  J Mater Sci Mater Med       Date:  1998-10       Impact factor: 3.896

5.  Immuno-electron-microscopic localization of types III pN-collagen and IV collagen, laminin and tenascin in developing and adult human spleen.

Authors:  A Liakka; H Karjalainen; I Virtanen; H Autio-Harmainen
Journal:  Cell Tissue Res       Date:  1995-10       Impact factor: 5.249

6.  Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach.

Authors:  O Tiitta; P Sipponen; V Gould; I Virtanen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Fibrillin-2, tenascin-C, matrilin-2, and matrilin-4 are strongly expressed in the epithelium of human granular and lattice type I corneal dystrophies.

Authors:  Eszter Szalai; Szabolcs Felszeghy; Zoltán Hegyi; László Módis; András Berta; Kai Kaarniranta
Journal:  Mol Vis       Date:  2012-07-18       Impact factor: 2.367

8.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

9.  Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155.

Authors:  Anna M Piccinini; Kim S Midwood
Journal:  Cell Rep       Date:  2012-10-19       Impact factor: 9.423

10.  Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.

Authors:  T Jahkola; T Toivonen; I Virtanen; K von Smitten; S Nordling; K von Boguslawski; C Haglund; H Nevanlinna; C Blomqvist
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.